Mitogen-activated protein kinase 9 — Drug Target

All drugs that target Mitogen-activated protein kinase 9 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

furaltadone

Phase 2 pipeline (1)

• Furazolin · furaltadone · Other
  Furazolin works by inhibiting the activity of Mitogen-activated protein kinase 9 (MAPK9), a protein involved in cell signaling pathways.